close
MENU
Hot Topic DEALMAKERS
Hot Topic DEALMAKERS
Shoeshine
9 mins to read

Has Greenfern Industries turned over a new leaf?

ANALYSIS: Like many other medicinal cannabis companies, Greenfern is about to attempt raising more capital but some offers may be better than others. 

WATCH: Simon Shepherd speaks with NBR senior journalist Fiona Rotherham.

Medicinal cannabis company Greenfern Industries has had what Shoeshine euphemistically describes as a ‘chequered past’ since being set up in 2018 when the industry started to kick off.

Its past involves a director scandal, unrevealed conflicts of interest, high related-party payments, and a

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Mon, 14 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Has Greenfern Industries turned over a new leaf?
Shoeshine,
106226
true